Rituximab as second-line treatment for adult immune...

The Lancet 2015 / 04 Vol. 385; Iss. 9978

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial

Ghanima, Waleed, Khelif, Abderrahim, Waage, Anders, Michel, Marc, Tjønnfjord, Geir E, Romdhan, Neila Ben, Kahrs, Johannes, Darne, Bernadette, Holme, Pål Andrè
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
385
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(14)61495-1
Date:
April, 2015
File:
PDF, 571 KB
english, 2015
Conversion to is in progress
Conversion to is failed